Cat. No.: X22-05-ZQ329
Styraxlignolide F
Synonym: 823214-06-8; Styraxlignolide f; (3S,4S)-3-[(3,4-Dimethoxyphenyl)methyl]-4-[[3-methoxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl]oxolan-2-one
- CAS Number: 823214-06-8
- Compound CID: 11330069
Product Size
20 mg; 50 mg; 100 mg; 200 mg
Properties
Description
Styraxlignolide F has been shown to inhibit the growth of cancer cells in vitro. It has been shown to be synergistic with other anticancer compounds and has been found to have an inhibition rate of up to 50% against cancer cells in culture. This compound is effective against both human lung and kidney cell lines, which are two common types of cancer. Styraxlignolide F is thought to work by inhibiting protein synthesis, leading to the death of cancer cells. This product is widely used in research in the fields of pharmaceuticals, cosmetics and health products.
Molecular Formula
C27H34O11
Identity
Confirmed by MS and NMR.
Applications
Styraxlignolide F is widely used in research in the fields of pharmaceuticals, cosmetics and health products.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Related Products
